Company News: King Pharmaceuticals

Share this article:
King Pharmaceuticals reported full-year revenue up 14% to $1.78 billion. Highlights of the year included the company's acquisition of Alpharma and winning US marketing approval for pain drug Embeda.

Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.